Michael Becka
Michael Becka publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms and Venous Thromboembolism Diagnosis and Management.
- World rank
- #344,385 of 7,710,434 ranked researchers
- Rank in Germany
- #17,078 of 364,343
- Works
- 60
- Citations
- 6.8k
- Citations per work
- 114.0
What does Michael Becka research?
Michael Becka's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3150.9%
- Everything else2540.9%
- Life Sciences58.2%
- 1Cardiology and Cardiovascular Medicine27% of their works
- 2Hematology11% of their works
- 3Internal Medicine9% of their works
- 4Molecular Biology4% of their works
- 5Immunology4% of their works
- 6Nutrition and Dietetics4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Vitamin K Research Studies
- Mast cells and histamine
- Antiplatelet Therapy and Cardiovascular Diseases
- Computational Drug Discovery Methods
- Cardiac Arrhythmias and Treatments
Which keywords describe Michael Becka's research?
The keywords of their largest research topics: Antithrombotic Therapy, Catheter Ablation, Anticoagulant Therapy, Atrial Fibrillation, Inflammation, Protease-Activated Receptors, Thrombin and Pulmonary Embolism.
- Ventricular Tachycardia
- Arrhythmias
- Clopidogrel
- Allergic Disease
- Bone Health
- Pulmonary Embolism
- Protease-Activated Receptors
- Atrial Fibrillation
- Catheter Ablation
- Antithrombotic Therapy
- Anticoagulant Therapy
- Inflammation
- Thrombin
- Venous Thromboembolism
- Vitamin K
- Aspirin
- Mast Cells
- Molecular Docking
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antithrombotic Therapy312 topics
- Catheter Ablation282 topics
- Anticoagulant Therapy251 topic
- Atrial Fibrillation251 topic
- Inflammation212 topics
- Protease-Activated Receptors171 topic
- Thrombin171 topic
- Pulmonary Embolism141 topic
- Venous Thromboembolism141 topic
- Bone Health51 topic
- Vitamin K51 topic
- Allergic Disease41 topic
- Aspirin41 topic
- Clopidogrel41 topic
- Mast Cells41 topic
- Arrhythmias31 topic
- Molecular Docking31 topic
- Ventricular Tachycardia31 topic
- Virtual Screening31 topic
Where does Michael Becka work?
Michael Becka's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Michael Becka have?
OpenAlex counts 60 works and 6,840 citations for Michael Becka, an h-index of 27, ranking #344,385 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Becka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.